Dosar de subiect
Medicament reutilizat creste supravietuirea in cancer ovarian agresiv
Primul articol: 10 apr. 2026, 22:55
|
Ultima actualizare: 10 apr. 2026, 22:55
|
1 sursa
|
1 articol
Mai multe surse. Mai putina manipulare.
Analiza editoriala
Bazat pe 1 sursa, 1 articol
Un nou studiu a demonstrat ca un medicament reutilizat ar putea creste semnificativ rata de supravietuire in cazul cancerului ovarian agresiv. Cercetatorii sunt optimisti cu privire la potentialul acestui tratament de a imbunatati prognosticul pacientelor. Sunt necesare studii suplimentare pentru a confirma aceste rezultate si a determina modul optim de utilizare a medicamentului.Articole despre acest subiect
Foto: The Guardian
Repurposed drug may extend survival in aggressive ovarian cancer, trial shows
Relacorilant, typically used to treat Cushing’s syndrome, could improve outcomes in platinum-resistant casesA drug originally used to treat a rare disease could extend the lives of patients with an aggressive form of ovarian cancer, according to a clinical trial.Platinum-resistant ovarian cancer occurs when the disease progresses within six months of starting platinum-based chemotherapy. This form of chemotherapy is different from other types because it uses compounds that contain platinum to de
Citeste pe The Guardian →